Marburg, Germany

Gerhard Seemann


Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 673(Granted Patents)


Location History:

  • Marburg-Einhausen, DE (1998)
  • Marburg-Elnhausen, DE (1997 - 2000)
  • Marburg, DE (1996 - 2010)

Company Filing History:


Years Active: 1996-2010

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Gerhard Seemann: Innovator in Antibody and Cancer Treatment Technologies

Introduction

Gerhard Seemann, based in Marburg, Germany, is a prominent inventor known for his contributions to the field of biopharmaceuticals. With a remarkable portfolio of 19 patents, he has dedicated his career to developing innovative solutions for diagnosing and treating tumors.

Latest Patents

Seemann’s recent patents highlight his expertise in antibody technology and cancer treatment. One notable invention is the "Chimeric antibody against tumor associated antigens and its use in diagnosing tumors." This invention focuses on murine monoclonal antibodies directed against tumor-associated antigens, detailing the nearly complete nucleotide sequences of the variable genes involved. The development of chimeric or 'humanized' monoclonal antibodies aims to improve human therapy and in vivo diagnosis, eliminating the drawbacks associated with traditional murine antibodies.

Another significant patent is for "Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates." This invention addresses the preparation of glycosyl-etoposide prodrugs and their application in treating various cancers through advanced conjugate therapies.

Career Highlights

Gerhard Seemann has held positions in reputable companies such as Behringwerke Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His work at these institutions has paved the way for several groundbreaking therapies that have the potential to advance cancer treatment methodologies.

Collaborations

Throughout his career, Seemann has collaborated with esteemed colleagues, including Klaus Bosslet and Peter Pfleiderer. These partnerships have contributed to the successful development of innovative therapeutic approaches and have expanded the scope of research in antibody technologies.

Conclusion

Gerhard Seemann's impressive record of patents and collaborations underscores his significant impact on the fields of immunotherapy and cancer treatment. His inventions not only enhance the understanding of tumor biology but also provide vital tools for improving patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…